Cellectar Biosciences
CLRB
CLRB
30 hedge funds and large institutions have $1.52M invested in Cellectar Biosciences in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 10 closing their positions.
Holders
30
Holders Change
-5
Holders Change %
-14.29%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
11
Reduced
5
Closed
10
Calls
$14K
Puts
$3K
Net Calls
+$11K
Net Calls Change
-$92K
Top Buyers
1 |
1
Squarepoint
New York
|
$156K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$112K |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$54.5K |
4 |
4
Two Sigma Investments
New York
|
$21.3K |
5 |
5
Bank of America
Charlotte,
North Carolina
|
$61.8K |